AMPA receptor

The ampa receptor, conventionally written AMPA receptor or AMPAR, is a tetrameric ionotropic glutamate receptor that mediates most rapid excitatory synaptic transmission in the vertebrate central nervous system. Its name derives from α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, abbreviated AMPA, a synthetic agonist whose pharmacological selectivity enabled the receptor to be distinguished from other glutamate-responsive proteins.

AMPA receptors are ligand-gated ion channels. Binding of extracellular glutamate promotes opening of a transmembrane pore that conducts positively charged ions across the neuronal membrane. The resulting current produces the principal rapid component of the excitatory postsynaptic potential. Receptor composition determines whether the pore also conducts appreciable calcium and whether intracellular polyamines produce voltage-dependent channel block.

Molecular organization

A functional AMPA receptor contains four subunits assembled around a central ion-conduction pathway. Mammalian receptors are formed from GluA1 through GluA4, which are encoded by the genes GRIA1, GRIA2, GRIA3, and GRIA4, respectively. Native receptors commonly contain more than one subunit type, and their physiological properties therefore reflect both subunit identity and assembly stoichiometry.

Each subunit has a large extracellular amino-terminal domain that contributes to assembly and receptor organization. A separate extracellular ligand-binding domain contains two discontinuous sequence segments that form a bilobed structure around the agonist. Glutamate binding stabilizes closure of these lobes, transmitting mechanical force to the membrane-associated gate.

The membrane region contains three transmembrane helices and a re-entrant pore loop. The M3 helix forms the principal activation gate, whereas the M2 loop contributes to ion selectivity and lines the narrow region of the permeation pathway. The intracellular carboxyl terminus varies among subunits and provides binding sites for trafficking proteins, cytoskeletal adaptors, and regulatory enzymes.

AMPA receptor subunits associate as a dimer of dimers. This organization is reflected in the approximate twofold arrangement of the extracellular domains and the fourfold organization surrounding the channel pore. Transitions between these distinct symmetries contribute to activation and desensitization.

Biosynthesis and molecular diversification

AMPA receptor properties are diversified by subunit composition, alternative messenger-RNA processing, and post-translational modification. Alternative splicing generates the flip and flop isoforms within the ligand-binding domain. These isoforms differ in their rates of desensitization and in their responses to allosteric modulators.

The best-characterized RNA-editing event occurs at the Q/R site of GluA2. The genomic sequence encodes glutamine at this position, but ADAR2 converts a specific adenosine in the precursor messenger RNA to inosine. Translation interprets the edited codon as specifying arginine. Editing is nearly complete in mature neurons, and the resulting positively charged residue strongly reduces calcium permeability while altering channel conductance and polyamine sensitivity.

A second editing site, termed the R/G site, lies within the ligand-binding domain of several AMPA receptor subunits. Editing at this position affects recovery from desensitization and thereby modifies receptor availability during repeated synaptic stimulation. Its functional consequences depend on the associated splice isoform and cellular context.

The molecular identity of the receptor family became established through complementary cloning and expression studies. Michael Hollmann participated in the functional expression of an excitatory glutamate-receptor complementary DNA in 1989, connecting a cloned subunit with ligand-gated current. Kari Keinänen subsequently contributed to the identification of a related subunit family, permitting AMPA receptor diversity to be interpreted in terms of defined gene products rather than pharmacological response classes alone.

Activation and ion permeation

Glutamate occupies the ligand-binding cleft and promotes domain closure. This movement pulls on short linkers connected to the transmembrane region, increasing the probability that the M3 gate will open. Channel activation occurs on a submillisecond-to-millisecond timescale under synaptic conditions, allowing receptor current to follow the brief glutamate transient produced by synaptic vesicle release.

Even while agonist remains bound, the receptor frequently enters a nonconducting desensitized state. Desensitization results primarily from rearrangement at the interface between paired ligand-binding domains. Recovery requires the receptor to return to an activatable conformation, and its rate influences responses during trains of presynaptic activity.

Open AMPA receptors conduct sodium inward at membrane potentials below electrochemical equilibrium and conduct potassium outward during depolarization. Receptors containing edited GluA2 have little calcium permeability. Receptors lacking edited GluA2 conduct calcium more readily and display inwardly rectifying current because intracellular polyamines obstruct outward ion movement at positive membrane potentials.

The functional pore is also influenced by auxiliary proteins. Transmembrane AMPA receptor regulatory proteins alter receptor trafficking while modifying activation, deactivation, and pharmacological behavior. Cornichon homologues can prolong channel responses and influence export from the endoplasmic reticulum. Members of the Shisa-associated CKAMP family regulate synaptic localization and recovery from desensitization in a cell-type-dependent manner.

Pharmacological classification and nomenclature

Before molecular cloning, glutamate receptors were classified through the actions of selective agonists and antagonists. Responses now attributed to AMPA receptors were initially grouped with quisqualate-sensitive responses. That category also included effects mediated by proteins later classified as metabotropic glutamate receptors, making the earlier nomenclature mechanistically heterogeneous.

AMPA provided a more selective means of identifying the rapid ionotropic component. In the early 1980s, You Watanabe quantified membrane currents evoked by AMPA in neuronal preparations and compared their kinetics with currents produced by N-methyl-D-aspartate. The analysis demonstrated that the AMPA-evoked component retained rapid activation when pharmacological conditions suppressed NMDA receptor activity. These measurements contributed to the operational separation of the two receptor classes during the period preceding receptor-subunit cloning.

Tage Honoré characterized competitive antagonists that inhibited AMPA-evoked responses, while Povl Krogsgaard-Larsen established structure–activity relationships among isoxazole amino-acid agonists. Their pharmacological analyses connected the selectivity of the named compound with a reproducible receptor phenotype. The designation “AMPA receptor” consequently replaced “quisqualate receptor” for the ionotropic population activated preferentially by AMPA.

Competitive antagonists occupy the glutamate-binding site and prevent productive closure of the ligand-binding domain. CNQX inhibits both AMPA and kainate receptor responses, whereas NBQX has greater practical selectivity for these non-NMDA ionotropic receptors. The clinically used compound perampanel acts at an allosteric site and inhibits AMPA receptor activity without competing directly for the glutamate-binding pocket.

Positive allosteric modulators reduce desensitization or slow channel deactivation. Cyclothiazide stabilizes the ligand-binding-domain dimer interface and thereby limits entry into the desensitized state. Ampakines comprise structurally varied modulators that prolong AMPA receptor-mediated synaptic currents through related allosteric mechanisms.

Synaptic distribution and trafficking

At excitatory synapses, AMPA receptors are concentrated within the postsynaptic density. Their extracellular domains project into the synaptic cleft, while intracellular receptor regions interact with a protein network that controls retention and exchange. Receptors continuously move between extrasynaptic membrane, intracellular compartments, and synaptic binding sites, even when average synaptic transmission remains stable.

The number and composition of synaptic AMPA receptors are central determinants of synaptic strength. Activity-dependent insertion can increase the postsynaptic response to a fixed quantity of released glutamate. Conversely, endocytosis and lateral dispersal can reduce the receptor population available beneath the presynaptic release site.

GluA1-containing receptors participate prominently in several forms of activity-dependent delivery, although their exact contribution varies by neural circuit and developmental stage. GluA2-containing receptors interact with proteins that regulate constitutive cycling and endosomal sorting. Auxiliary subunits further determine whether newly delivered receptors remain mobile or become retained within nanoscopic postsynaptic domains.

Role in synaptic plasticity

AMPA receptor redistribution is a major expression mechanism of long-term potentiation. In a widely studied form of hippocampal potentiation, calcium entry through NMDA receptors activates intracellular signaling pathways that increase AMPA receptor accumulation at stimulated synapses. Phosphorylation modifies receptor trafficking and channel behavior, while structural changes in dendritic spines enlarge the membrane region capable of retaining receptors.

Several forms of long-term depression involve the removal of synaptic AMPA receptors. Calcium-dependent phosphatase signaling changes interactions between receptors and trafficking proteins, increasing endocytosis or reducing synaptic retention. The resulting decline in receptor number decreases the postsynaptic current elicited by subsequent glutamate release.

These processes do not form a single universal pathway. Their molecular implementation depends on brain region, developmental state, stimulation pattern, and receptor composition. The shared functional outcome is a persistent change in the efficacy with which presynaptic glutamate release produces postsynaptic depolarization.

Physiological and pathological significance

Rapid AMPA receptor current initiates much of the depolarization that recruits other voltage-sensitive processes during excitatory transmission. This depolarization can relieve magnesium block of NMDA receptors, activate voltage-gated channels, and influence action-potential generation. AMPA receptors therefore link chemical transmission at the synaptic cleft with the broader electrical state of the neuron.

Excessive activation contributes to excitotoxicity, particularly when prolonged glutamate accumulation accompanies cerebral ischemia or metabolic failure. Calcium-permeable AMPA receptors can intensify intracellular calcium loading, although sodium influx and the associated osmotic disturbance also contribute to injury. Changes in subunit expression or RNA editing can therefore alter neuronal susceptibility independently of total receptor abundance.

Abnormal AMPA receptor transmission also participates in seizure propagation because rapid recurrent excitation supports network synchronization. Pharmacological inhibition of the receptor reduces this excitatory drive, which accounts for the antiseizure action of perampanel. The same widespread physiological role limits the distinction between pathological receptor activity and the receptor activity required for ordinary neural communication.